| 货号 |
中文名称 |
英文名词 |
靶点 |
|
VAPD00071 |
Research Grade Orticumab ( 奥替苏单抗 ) Biosimilar
|
|
oxLDL, Oxidized LDL |
|
VAPD00070 |
Research Grade Ontuxizumab ( 昂妥昔珠单抗 ) Biosimilar
|
|
CD248, CD164L1 |
|
VAPD00069 |
Research Grade Olokizumab ( 奥洛组单抗 ) Biosimilar
|
|
IL6,CDF |
|
VAPD00068 |
Research Grade Olaratumab ( 奥拉妥单抗 ) Biosimilar
|
|
CD140a |
|
VAPD00067 |
Research Grade Ofatumumab ( 奥法木单抗 ) Biosimilar
|
|
MS4A1, CD20, B-lymphocyte antigen CD20 |
|
VAPD00066 |
Research Grade Ocrelizumab ( 奥瑞组单抗 ) Biosimilar
|
|
MS4A2, APY, FCER1B, IGER, FcERI |
|
VAPD00065 |
Research Grade Obinutuzumab ( 阿托珠单抗 ) Biosimilar
|
|
MS4A1, CD20 |
|
VAPD00064 |
Research Grade Nivolumab ( 纳武单抗 ) Biosimilar
|
|
PDCD1, PD1, CD279 |
|
VAPD00063 |
Research Grade Necitumumab ( 奈妥木单抗 ) Biosimilar
|
|
EGFR, ERBB, ERBB1, HER1 |
|
VAPD00062 |
Research Grade Natalizumab ( 那他珠单抗 ) Biosimilar
|
|
ITGA4, CD49D |
